SCHEMBL22978677

SCHEMBL22978677

[CH2]Cc1cc(OCC)c(C)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.35
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ HTT P42858 3/20 0.33
▸ ALPL P05186 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ S1PR1 P21453 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ MAPT P10636 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ LNPEP Q9UIQ6 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9784641 0.81 S1PR1 (0.41) AOC3SLC6A2SLC6A4SLC6A3KDM4E
Hydrochloric Acid SCHEMBL9784650 0.80 KDM4E (0.39) AOC3SLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL22978614 0.80 HTT (0.36) AOC3KDM4EHTTTDP1ALDH1A1
SCHEMBL22978602 0.80 EGFR (0.37) KDM4EALDH1A1MAPK1HSD17B10CYP3A4
SCHEMBL13765676 0.75 GABRP (0.40) AOC3SLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL9784701 0.74 TSHR (0.39) KDM4EHTTALDH1A1MAPK1HSD17B10
SCHEMBL25004559 0.73 HPGD (0.39) AOC3SLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL19466204 0.73 ESR1 (0.38) AOC3SLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL13324326 0.70 KDM4E (0.49) KDM4EHTTALPLTDP1ALDH1A1
SCHEMBL13952464 0.69 PTGS2 (0.36) HTTALDH1A1MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026672-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS NOVARTIS AG (CH) 2021-02-18 — — WO disclosed
Send feedback